SCLX
NASDAQ · Pharmaceuticals
Scilex Holding Co
$1.98
+0.13 (+7.03%)
Open$1.89
Previous Close$1.85
Day High$2.09
Day Low$1.85
52W High$27.00
52W Low$2.01
Volume—
Avg Volume38.4K
Market Cap13.01M
P/E Ratio—
EPS$-48.45
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,846.0% upside
Current
$1.98
$1.98
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.66M | 19.06M | 16.86M |
| Net Income | -209,463,258 | -203,450,175 | 3.00M |
| Profit Margin | -1,185.8% | -1,126.5% | 17.8% |
| EBITDA | -203,776,283 | -208,922,370 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | -7.3% | -7.3% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |